ARCHIVES

Cancer Drugs Initiatives To Shorten approval Times, Ensure Post-Marketing Studies, FDA Official Says

This article is from The Cancer Letter archive.

Vol. 22 No. 17 | April 26, 1996

Download PDF Visit The Full Archive

Related Articles

RPR Grant To NABCO Does Not Support Advocacy, Firm Says

November 10, 1995

NCI Approved CTEP Trials For the Month of August

August 31, 2012

It’s Official – UCLA Recognize As 19th Comprehensive Center

January 7, 1977

NIH COI Rule Mandates More Disclosure, Leaves Institutions In Charge Of Ethics Of Extramural Researchers

September 16, 2011

IOM Review Of Duke Genomics Trials To Focus On Validation, Scientific Criteria

October 22, 2010

Bypass Budget Going to White House Next Month Will Seek Optimal Funding for Cancer Program

August 22, 1980